Medical Cannabis
Science-led insight on therapeutic use, formulations, and clinical best practice.
Medical Cannabis · page 10
- Medical Cannabis
German Health Insurance Companies No Longer Want to Cover the Costs of Cannabis Flower
In Germany, the partial legalisation of cannabis has opened up a new telemedicine market. Instead of visiting a doctor in person, patients can now request prescriptions online, with cannabis flowers sent directly to patients via specialist pharmacies.
- Medical Cannabis
Glass Pharms Signs Supply Agreement With CB1 Pharmacy Offering 3 New Affordable UK-Grown Strains
Glass Pharms has today announced a new supply deal set to see a new line of affordable, entirely UK-produced products enter the market.
- Medical Cannabis
Why France’s Strict Medical Cannabis Plans Could be its Secret Weapon
Augur Associates and Newsweed, two organisations at the forefront of the ongoing developments in the region, believe that the incoming system not only sidesteps many of the issues other countries have faced in the implementation phase, but that it could reestablish the country’s standing as a model of inspiration for neighbouring states and prospective forthcoming EU supra-regulation.
- Medical Cannabis
Not on Our Watch: Releaf Pushes Back Against Rushed Cannabis Prescribing
The British Medical Association (BMA), which represents tens of thousands of General Practitioners in the UK, this week threatened new strike action amid increasing tensions with the Starmer government.
- Medical Cannabis
Czech Republic to Decriminalise Cannabis from 2026 — But Medical Exports Already Booming
The Czech Republic has been pursuing a more relaxed cannabis policy for some time. In early June, the lower house of parliament approved a draft law amounting to partial legalisation. The Senate followed suit at the start of July, meaning cannabis will be fully decriminalised from 1 January next year.
- Industry Trends
Has Germany’s Medical Cannabis Market Peaked? New Laws, Surging Supply, and Industry Unrest
Over the past few years, telemedicine has reshaped how patients access medical cannabis, launching a wave of digital clinics across Europe and beyond.
- Medical Cannabis
‘Valuable’ UK Medical Cannabis Data to be Published After A Four Year Delay
The years of obfuscation and delay prompted a Freedom of Information request by Business of Cannabis, which has established that the NHS will publish data from its ‘registry’ by the ‘end of the year’.
